Handelsbanken Fonder’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.27M Buy
16,895
+2,200
+15% +$141K ﹤0.01% 1027
2026
Q1
$828K Hold
14,695
﹤0.01% 1125
2025
Q4
$1.18M Hold
14,695
﹤0.01% 963
2025
Q3
$716K Hold
14,695
﹤0.01% 1144
2025
Q2
$1.1M Sell
14,695
-1,100
-7% -$72.8K ﹤0.01% 920
2025
Q1
$1M Hold
15,795
﹤0.01% 936
2024
Q4
$1.23M Sell
15,795
-1,300
-8% -$104K ﹤0.01% 872
2024
Q3
$1.37M Buy
17,095
+3,300
+24% +$267K 0.01% 807
2024
Q2
$1.14M Buy
13,795
+4,400
+47% +$387K 0.01% 785
2024
Q1
$802K Hold
9,395
﹤0.01% 936
2023
Q4
$803K Hold
9,395
﹤0.01% 896
2023
Q3
$842K Hold
9,395
﹤0.01% 792
2023
Q2
$800K Hold
9,395
﹤0.01% 832
2023
Q1
$777K Hold
9,395
﹤0.01% 789
2022
Q4
$739K Hold
9,395
﹤0.01% 760
2022
Q3
$696K Hold
9,395
﹤0.01% 788
2022
Q2
$612K Hold
9,395
﹤0.01% 908
2022
Q1
$594K Hold
9,395
﹤0.01% 1083
2021
Q4
$498K Hold
9,395
﹤0.01% 1345
2021
Q3
$663K Hold
9,395
﹤0.01% 1151
2021
Q2
$626K Buy
9,395
+500
+6% +$35.4K ﹤0.01% 1213
2021
Q1
$987K Hold
8,895
0.01% 848
2020
Q4
$1.06M Hold
8,895
0.01% 805
2020
Q3
$776K Hold
8,895
0.01% 805
2020
Q2
$797K Buy
+8,895
New +$898K 0.01% 777

Other funds holding HAE

Handelsbanken Fonder's HAE Position: Q2 2026 in Review

Handelsbanken Fonder increased its Haemonetics (HAE) stake by 15% in Q2 2026, buying an estimated $141K and bringing the position to 16,895 shares worth $1.27M. The position accounts for ﹤0.01% of the portfolio, ranked #1027.

Handelsbanken Fonder first reported a position in HAE in Q2 2020 and has held it in 25 quarters since. The position peaked at $1.37M in Q3 2024. 202 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Handelsbanken Fonder held 16,895 shares of Haemonetics worth $1.27M as of Q2 2026.
  • Handelsbanken Fonder bought 2,200 Haemonetics shares in Q2 2026, an estimated $141K.
  • Haemonetics made up ﹤0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #1027 holding.
  • Handelsbanken Fonder first reported a position in Haemonetics in Q2 2020 and has held it in 25 quarters since.
  • Handelsbanken Fonder's Haemonetics position peaked at $1.37M in Q3 2024.
  • 202 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.